SCHEMBL27458167

SCHEMBL27458167

CC(=O)OC(C)c1cn(Cc2ccccc2)c2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
POLB P06746 2/20 0.58
USP2 O75604 1/20 0.58
HSD17B10 Q99714 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.52
MAPK1 P28482 2/20 0.51
LMNA P02545 2/20 0.50
CNR1 P21554 1/20 0.49
CNR2 P34972 1/20 0.49
ADORA1 P30542 1/20 0.49
NPSR1 Q6W5P4 3/20 0.48
KMT2A Q03164 2/20 0.48
HTT P42858 2/20 0.48
MEN1 O00255 1/20 0.48
KDM1A O60341 1/20 0.47
F2RL3 Q96RI0 1/20 0.46
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31058835 0.81 ALDH1A1 (0.67) ALDH1A1POLBUSP2HSD17B10L3MBTL1
SCHEMBL2006753 0.81 ALDH1A1 (0.67) ALDH1A1POLBUSP2HSD17B10L3MBTL1
SCHEMBL11974276 0.79 ALDH1A1 (0.59) ALDH1A1POLBUSP2HSD17B10L3MBTL1
SCHEMBL29439910 0.76 ALDH1A1 (0.76) ALDH1A1POLBUSP2HSD17B10L3MBTL1
SCHEMBL5329303 0.76 ALDH1A1 (0.76) ALDH1A1POLBUSP2HSD17B10L3MBTL1
SCHEMBL9056926 0.76 LMNA (0.58) ALDH1A1POLBL3MBTL1MAPK1LMNA
SCHEMBL9584660 0.75 ALDH1A1 (0.63) ALDH1A1POLBUSP2HSD17B10L3MBTL1
SCHEMBL27927350 0.75 KMT2A (0.40) ALDH1A1POLBNPSR1KMT2AHTT
SCHEMBL28807609 0.74 ALDH1A1 (0.72) ALDH1A1POLBUSP2HSD17B10L3MBTL1
SCHEMBL6655554 0.74 ALDH1A1 (0.54) ALDH1A1POLBUSP2HSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1141627-A Indole derivatives for the treatment of estrogen-related tumors and diseases MERRELL DOW PHARMA (US) 1997-01-29 CN disclosed